Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 |
|---|---|---|---|
| Revenue | 1.85B | 1.59B | 1.37B |
| Cost of revenue | 1.66B | 1.36B | 1.17B |
| Gross profit | 192M | 229M | 200M |
| Research and development | 17M | 10M | 12M |
| Selling, general and administrative | 89M | 127M | 115M |
| Operating expenses | 185M | 189M | 219M |
| Operating income | 7M | 41M | −19M |
| Interest expense | 3M | 2M | 3M |
| Pre-tax income | 50M | −41M | 49M |
| Income tax | 8M | 11M | −30M |
| Net income | 43M | −52M | 99M |
| Earnings per share | 0.59 | −0.75 | 1.42 |
| Earnings per share, diluted | 0.59 | −0.75 | 1.42 |
| Weighted average shares | 73M | 70M | 70M |
| Weighted average shares, diluted | 73M | 70M | 70M |
| Metric | 19/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 144M | 127M | 185M | 308M |
| Receivables | — | 343M | 288M | — | — |
| Inventory | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 |
|---|---|---|---|
| Operating cash flow | 12M | 6M | 12M |
| Depreciation and amortisation | 11M | 10M | 8M |
| Capital expenditure | 27,000 | 1M | 95M |
| Investing cash flow | −93M | −11M | −23M |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2M |
| 4M |
| — |
| — |
| Current assets | — | 937M | 667M | — | — |
| Property, plant and equipment | — | 62M | 147M | — | — |
| Total assets | — | 1.24B | 908M | — | — |
| Current liabilities | — | 464M | 290M | — | — |
| Long-term debt | — | — | 1M | — | — |
| Total liabilities | — | 490M | 319M | — | — |
| Equity | — | 734M | 570M | 670M | −384M |
| Shares outstanding | — | 76M | 7M | — | — |
| Shares issued | — | 76M | 7M | — | — |
| 99M |
| −54M |
| −232M |